Skip to main content
AI Market Summary
Loading market intelligence...

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZIONO) Stock Forecast 2025 - AI Price Prediction & Analysis


ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZIONO) AI Stock Price Forecast & Investment Analysis

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ Stock Price Chart and Technical Analysis

Loading ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ interactive price chart and technical analysis...

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZIONO) - Comprehensive Stock Analysis & Investment Research

Deep dive into ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/: ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ operates in the Finance sector, establishing it as a mid-cap growth opportunity.

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (Stock Symbol: ZIONO) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/: With $616M in annual revenue and 112.7% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $616 million generating a 112.7% net profit margin .

Market Capitalization: $3699 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/: Market positioning analysis based on available financial and operational metrics.

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ strategically competes in the highly dynamic National Commercial Banks marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZIONO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock analysis.

Loading ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ comprehensive fundamental analysis and insider trading data...

Deep dive into ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/: With a P/E ratio of 5.81, the market sees the stock as potentially undervalued.

P/E Ratio 5.81x
P/B Ratio 0.58x
Market Cap $3699M
Dividend Yield 0.03%
EPS $4.39
Book Value/Share $43.23
Revenue/Share $3.41
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/:

Net Margin 112.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/:

Understanding Financial Statement Data

What these metrics mean: Key figures from ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/: With annual revenue of $616M, ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $616M
Net Income $694M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Dividends Per Share $0.82
Payout Ratio 0.2%
Shares Outstanding 148M
Growth Metrics (YoY)
EPS Growth 17.5%

Latest ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZIONO) stock price and investment outlook.

📰 We are currently updating our news feed for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/. Check back soon for the latest market analysis and company updates.

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ Competitors & Peer Analysis - Finance Sector

Comparative analysis of ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $591M 11.7x 1.1x
AMJB Unlock Forecast - 30 Days FREE Trial $84387M 1.5x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $861M 12.9x 0.9x
AROW Unlock Forecast - 30 Days FREE Trial $543M 15.8x 1.3x
ASRV Unlock Forecast - 30 Days FREE Trial $52M 10.3x 0.5x
ATLO Unlock Forecast - 30 Days FREE Trial $211M 13.2x 1.1x
BAC Unlock Forecast - 30 Days FREE Trial $401726M 13.6x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $183822M 6.2x 0.6x
BAC-PE Unlock Forecast - 30 Days FREE Trial $142411M 4.8x 0.5x
BAC-PK Unlock Forecast - 30 Days FREE Trial $182503M 6.2x 0.6x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9308366M 314.0x 30.6x
BAC-PM Unlock Forecast - 30 Days FREE Trial $163080M 5.5x 0.5x
BAC-PN Unlock Forecast - 30 Days FREE Trial $151592M 5.1x 0.5x
BAC-PO Unlock Forecast - 30 Days FREE Trial $132149M 4.5x 0.4x
BAC-PP Unlock Forecast - 30 Days FREE Trial $124967M 4.2x 0.4x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $128925M 4.4x 0.4x
BAC-PS Unlock Forecast - 30 Days FREE Trial $143144M 4.8x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1722414M 58.1x 5.7x
BANC Unlock Forecast - 30 Days FREE Trial $2973M 14.3x 0.9x
BANC-PF Unlock Forecast - 30 Days FREE Trial $3774M 18.1x 1.1x
BANF Unlock Forecast - 30 Days FREE Trial $3791M 16.0x 2.1x
BANFP Unlock Forecast - 30 Days FREE Trial $875M 3.7x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $636M 13.6x 1.1x
BFC Unlock Forecast - 30 Days FREE Trial $1333M 18.9x 2.1x
BHRB Unlock Forecast - 30 Days FREE Trial $1057M 9.9x 1.3x
BML-PG Unlock Forecast - 30 Days FREE Trial $137720M 4.6x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $137427M 4.6x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $145342M 4.9x 0.5x
BML-PL Unlock Forecast - 30 Days FREE Trial $140139M 4.7x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $9193M 17.1x 1.5x
C Unlock Forecast - 30 Days FREE Trial $210520M 14.3x 1.0x
CAC Unlock Forecast - 30 Days FREE Trial $775M 13.5x 1.2x
CARE Unlock Forecast - 30 Days FREE Trial $448M 14.4x 1.1x
CASH Unlock Forecast - 30 Days FREE Trial $1732M 24.7x 2.0x
CBKM Unlock Forecast - 30 Days FREE Trial $73M 10.8x 0.9x
CBNA Unlock Forecast - 30 Days FREE Trial $249M 13.4x 1.5x
CBNK Unlock Forecast - 30 Days FREE Trial $496M 10.0x 1.3x
CBU Unlock Forecast - 30 Days FREE Trial $3181M 15.5x 1.6x
CFBK Unlock Forecast - 30 Days FREE Trial $151M 9.3x 0.8x
CFNB Unlock Forecast - 30 Days FREE Trial $237M 47.5x 1.2x
CFR Unlock Forecast - 30 Days FREE Trial $8317M 13.1x 1.9x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1141M 1.8x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1831M 14.4x 2.3x
CMA Unlock Forecast - 30 Days FREE Trial $11542M 16.1x 1.3x
CMTV Unlock Forecast - 30 Days FREE Trial $142M 8.6x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $153600M 108.6x 1.4x
COF-PI Unlock Forecast - 30 Days FREE Trial $12098M 8.6x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $11593M 8.2x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $11138M 7.9x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $10560M 7.5x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $10458M 7.4x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $56830M 3.9x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1383M 23.7x 1.0x
DCOMG Unlock Forecast - 30 Days FREE Trial $1152M 19.7x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $796M 13.6x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $130M 6.6x 0.9x
FCF Unlock Forecast - 30 Days FREE Trial $1802M 12.6x 1.2x
FDBC Unlock Forecast - 30 Days FREE Trial $286M 11.0x 1.3x
FFBC Unlock Forecast - 30 Days FREE Trial $2581M 10.0x 1.0x
FHN Unlock Forecast - 30 Days FREE Trial $12243M 13.8x 1.4x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13032M 14.7x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $12795M 14.4x 1.4x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9452M 10.7x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2463M x 4.0x
FISI Unlock Forecast - 30 Days FREE Trial $657M 8.1x 1.1x
FMCB Unlock Forecast - 30 Days FREE Trial $794M 8.7x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $6337M 12.5x 1.0x
FNLC Unlock Forecast - 30 Days FREE Trial $317M 10.1x 1.2x
FRME Unlock Forecast - 30 Days FREE Trial $2230M 9.6x 0.9x
FRMEP Unlock Forecast - 30 Days FREE Trial $1464M 6.3x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $1072M 12.0x 1.0x
FULT Unlock Forecast - 30 Days FREE Trial $3658M 10.1x 1.1x
FULTP Unlock Forecast - 30 Days FREE Trial $3505M 9.7x 1.0x
FUNC Unlock Forecast - 30 Days FREE Trial $266M 10.7x 1.3x
GNTY Unlock Forecast - 30 Days FREE Trial $553M 15.3x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $868M 12.0x 1.1x
HBAN Unlock Forecast - 30 Days FREE Trial $25729M 11.6x 1.2x
HBANL Unlock Forecast - 30 Days FREE Trial $37578M 16.9x 1.7x
HBANM Unlock Forecast - 30 Days FREE Trial $32194M 14.5x 1.5x
HBANP Unlock Forecast - 30 Days FREE Trial $25357M 11.4x 1.1x
HOPE Unlock Forecast - 30 Days FREE Trial $1474M 30.5x 0.7x
HWBK Unlock Forecast - 30 Days FREE Trial $244M 11.0x 1.5x
JPM Unlock Forecast - 30 Days FREE Trial $882025M 15.2x 2.5x
JPM-PC Unlock Forecast - 30 Days FREE Trial $70383M 1.2x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $69600M 1.2x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $56634M 1.0x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $54339M 0.9x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $55149M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $50593M 0.9x 0.1x
KEY Unlock Forecast - 30 Days FREE Trial $22811M 21.2x 1.1x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27543M 25.6x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $23442M 21.8x 1.2x
KEY-PK Unlock Forecast - 30 Days FREE Trial $23298M 21.7x 1.2x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27543M 25.6x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $167806M 9690.3x 1077.6x
LCNB Unlock Forecast - 30 Days FREE Trial $248M 10.5x 0.9x
MER-PK Unlock Forecast - 30 Days FREE Trial $188000M 6.3x 0.6x
MFG Unlock Forecast - 30 Days FREE Trial $18673M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $203M 10.0x 1.1x
MZHOF Unlock Forecast - 30 Days FREE Trial $95139M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1515M 12.4x 1.1x
NBTB Unlock Forecast - 30 Days FREE Trial $2227M 14.9x 1.2x
NEWT Unlock Forecast - 30 Days FREE Trial $350M 5.9x 0.9x
NEWTG Unlock Forecast - 30 Days FREE Trial $723M 12.2x 1.9x
NEWTH Unlock Forecast - 30 Days FREE Trial $731M 12.3x 1.9x
NEWTI Unlock Forecast - 30 Days FREE Trial $718M 12.1x 1.9x
NEWTZ Unlock Forecast - 30 Days FREE Trial $724M 12.2x 1.9x
NIC Unlock Forecast - 30 Days FREE Trial $1958M 13.5x 1.6x
NKSH Unlock Forecast - 30 Days FREE Trial $215M 16.5x 1.2x
NWBI Unlock Forecast - 30 Days FREE Trial $1867M 16.5x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1160M 14.5x 0.7x
ONB Unlock Forecast - 30 Days FREE Trial $8984M 14.8x 1.1x
ONBPO Unlock Forecast - 30 Days FREE Trial $9838M 16.2x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9793M 16.2x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $51M 3.3x 0.4x
PFIS Unlock Forecast - 30 Days FREE Trial $527M 9.9x 1.0x
PNFP Unlock Forecast - 30 Days FREE Trial $7788M 12.5x 1.1x
PNFPP Unlock Forecast - 30 Days FREE Trial $1939M 3.1x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2665M 15.1x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $24814M 11.5x 1.3x
RF-PC Unlock Forecast - 30 Days FREE Trial $21220M 9.8x 1.1x
RF-PE Unlock Forecast - 30 Days FREE Trial $15695M 7.3x 0.8x
RF-PF Unlock Forecast - 30 Days FREE Trial $22866M 10.6x 1.2x
SFNC Unlock Forecast - 30 Days FREE Trial $2803M 14.1x 0.8x
SFST Unlock Forecast - 30 Days FREE Trial $451M 17.3x 1.3x
SHBI Unlock Forecast - 30 Days FREE Trial $623M 11.0x 1.1x
SMBK Unlock Forecast - 30 Days FREE Trial $667M 14.4x 1.2x
SNNF Unlock Forecast - 30 Days FREE Trial $18M x 0.8x
SNV Unlock Forecast - 30 Days FREE Trial $7340M 9.2x 1.3x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3519M 4.4x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3641M 4.6x 0.6x
STEL Unlock Forecast - 30 Days FREE Trial $1660M 16.3x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $3056M 13.4x 3.9x
TRMK Unlock Forecast - 30 Days FREE Trial $2452M 11.0x 1.2x
UBFO Unlock Forecast - 30 Days FREE Trial $181M 15.9x 1.3x
UBOH Unlock Forecast - 30 Days FREE Trial $121M 10.7x 1.5x
UMBF Unlock Forecast - 30 Days FREE Trial $9047M 14.9x 1.2x
UMBFO Unlock Forecast - 30 Days FREE Trial $2040M 3.4x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $83360M 11.6x 1.3x
USB-PA Unlock Forecast - 30 Days FREE Trial $1216020M 169.2x 19.2x
USB-PH Unlock Forecast - 30 Days FREE Trial $28880M 4.0x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $36309M 5.1x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $24196M 3.4x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $25755M 3.6x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $28639M 4.0x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $235M 13.2x 1.3x
VLY Unlock Forecast - 30 Days FREE Trial $6716M 13.0x 0.9x
VLYPN Unlock Forecast - 30 Days FREE Trial $14504M 28.0x 1.9x
VLYPO Unlock Forecast - 30 Days FREE Trial $14284M 27.6x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14318M 27.6x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $77385M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1237M 10.3x 1.3x
WAFD Unlock Forecast - 30 Days FREE Trial $2591M 11.5x 0.9x
WAFDP Unlock Forecast - 30 Days FREE Trial $1321M 5.8x 0.4x
WBHC Unlock Forecast - 30 Days FREE Trial $2123M 31.1x 3.8x
WBS Unlock Forecast - 30 Days FREE Trial $10570M 11.4x 1.1x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3178M 3.4x 0.3x
WBS-PG Unlock Forecast - 30 Days FREE Trial $3914M 4.2x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $290297M 13.8x 1.6x
WFCNP Unlock Forecast - 30 Days FREE Trial $6298M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $60522M 2.9x 0.3x
WFC-PC Unlock Forecast - 30 Days FREE Trial $56145M 2.7x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $55263M 2.6x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $3857371M 183.2x 21.3x
WFC-PY Unlock Forecast - 30 Days FREE Trial $76077M 3.6x 0.4x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $61278M 2.9x 0.3x
WSBC Unlock Forecast - 30 Days FREE Trial $3376M 18.6x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2400M 18.0x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3319M 11.9x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $8733M 10.3x 1.3x
ZIONP Unlock Forecast - 30 Days FREE Trial $2991M 3.5x 0.4x

Frequently Asked Questions - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ Stock Forecast

How accurate are ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock predictions?

Our AI model shows a 13% Spearman correlation coefficient for ZIONO predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock price forecasts?

Our analysis considers ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ a good investment in 2025?

Based on our AI analysis, ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ forecasts updated?

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ stock.

My Portfolio

Investment Dashboard

Loading your portfolio...